Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe

NCT04565821 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04565821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04565821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 12, 2020
Completion date
April 30, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, environmental enteropathy, inflammatory bowel diseases, inflammatory disease, permeability; increased